---
created: '2026-02-13T14:58:21.713770Z'
description: An NAD+ precursor that efficiently raises cellular NAD+ levels via the
  NRK pathway. Also known as NR, it bypasses some limitations of other NAD+ precursors
  and has demonstrated safety and efficacy in human clinical trials for boosting NAD+
  metabolism.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/supplement/nicotinamide-riboside/
slug: nicotinamide-riboside
tags:
- supplement
- nad_precursor
- longevity
- energy
- mitochondrial
- sirtuin_activator
templateEngineOverride: njk
title: Nicotinamide Riboside
type: supplement
updated: '2026-02-13T14:58:21.713770Z'
---

{% raw %}
<h1>Nicotinamide Riboside</h1>
<h2>Overview</h2>
<p>Nicotinamide Riboside (NR) is a form of vitamin B3 that serves as a direct precursor to NAD+ (nicotinamide adenine dinucleotide). It was identified as an NAD+ precursor in 2004 and has since become one of the most studied longevity supplements.</p>
<p>NR has several advantages over other NAD+ precursors:</p>
<ul>
<li><strong>No flushing</strong> (unlike niacin)</li>
<li><strong>Efficient pathway</strong> (via NRK enzymes)</li>
<li><strong>Bypasses NAMPT</strong> (age-related decline in NAMPT doesn't limit NR)</li>
<li><strong>Well-studied</strong> (multiple human clinical trials)</li>
</ul>
<h2>NAD+ Biosynthesis Pathways</h2>
<h3>NR → NAD+ (Salvage via NRK)</h3>
<ol>
<li><strong>NRK1/NRK2</strong>: NR + ATP → NMN + ADP</li>
<li><strong>NMNAT1-3</strong>: NMN + ATP → NAD+ + PPi</li>
</ol>
<h3>Comparison with Other Precursors</h3>
<table>
<thead>
<tr>
<th>Precursor</th>
<th>Pathway</th>
<th>Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>NR</strong></td>
<td>NRK → NMN → NAD+</td>
<td>Efficient, no flush</td>
</tr>
<tr>
<td><strong>NMN</strong></td>
<td>NMNAT → NAD+</td>
<td>Direct, but larger molecule</td>
</tr>
<tr>
<td><strong>Nicotinamide</strong></td>
<td>NAMPT → NMN → NAD+</td>
<td>Rate-limited by NAMPT</td>
</tr>
<tr>
<td><strong>Niacin</strong></td>
<td>Preiss-Handler</td>
<td>Causes flushing</td>
</tr>
<tr>
<td><strong>Tryptophan</strong></td>
<td>De novo synthesis</td>
<td>Very inefficient</td>
</tr>
</tbody>
</table>
<h2>Effects on NAD+ Metabolism</h2>
<h3>NAD+ Elevation</h3>
<ul>
<li>Human studies show 40-90% increase in blood NAD+</li>
<li>Dose-dependent response (100-1000 mg)</li>
<li>Effects seen within 1-2 weeks</li>
</ul>
<h3>Downstream Effects</h3>
<ul>
<li><strong>SIRT1 activation</strong>: Metabolic regulation, longevity</li>
<li><strong>SIRT3 activation</strong>: Mitochondrial function</li>
<li><strong>PARP support</strong>: DNA repair</li>
<li><strong>CD38</strong>: Still consumes NAD+ (potential limitation)</li>
</ul>
<h2>Clinical Evidence</h2>
<h3>Human Trials</h3>
<p><strong>Martens et al., 2018</strong> (Nature Communications)</p>
<ul>
<li>24 adults, 500 mg NR × 6 weeks</li>
<li>Reduced blood pressure</li>
<li>Reduced arterial stiffness</li>
<li>Well tolerated</li>
</ul>
<p><strong>Dollerup et al., 2018</strong> (American Journal of Clinical Nutrition)</p>
<ul>
<li>40 obese men, 1000 mg NR × 12 weeks</li>
<li>Increased NAD+ metabolome</li>
<li>No effect on insulin sensitivity</li>
<li>Safe and well tolerated</li>
</ul>
<p><strong>Elhassan et al., 2019</strong> (Cell Reports)</p>
<ul>
<li>12 adults, 1000 mg NR × 3 weeks</li>
<li>Increased NAD+ in muscle</li>
<li>Altered mitochondrial bioenergetics</li>
<li>Gene expression changes</li>
</ul>
<h3>Key Findings</h3>
<ul>
<li>Consistent NAD+ elevation across trials</li>
<li>Cardiovascular benefits in some studies</li>
<li>Muscle/mitochondrial effects observed</li>
<li>Generally safe with mild side effects</li>
</ul>
<h2>Mechanism Connections</h2>
<h3>Sirtuin Activation</h3>
<ul>
<li>NAD+ is required substrate for sirtuins</li>
<li>SIRT1: Nuclear metabolism, longevity</li>
<li>SIRT3: Mitochondrial metabolism</li>
<li>Links energy status to gene regulation</li>
</ul>
<h3>Mitochondrial Biogenesis</h3>
<ul>
<li>Via SIRT1 → PGC-1α pathway</li>
<li>NR increases mitochondrial function markers</li>
<li>Supports oxidative metabolism</li>
</ul>
<h3>DNA Repair</h3>
<ul>
<li>NAD+ supports PARP enzyme function</li>
<li>Critical for genome maintenance</li>
<li>May contribute to longevity effects</li>
</ul>
<h2>Comparison: NR vs NMN</h2>
<table>
<thead>
<tr>
<th>Factor</th>
<th>NR</th>
<th>NMN</th>
</tr>
</thead>
<tbody>
<tr>
<td>Molecular weight</td>
<td>255 Da</td>
<td>334 Da</td>
</tr>
<tr>
<td>Transport</td>
<td>Enters cells directly</td>
<td>May require conversion</td>
</tr>
<tr>
<td>Price</td>
<td>Generally lower</td>
<td>Generally higher</td>
</tr>
<tr>
<td>Human trials</td>
<td>More published</td>
<td>Fewer (but increasing)</td>
</tr>
<tr>
<td>NAD+ elevation</td>
<td>Confirmed</td>
<td>Confirmed</td>
</tr>
<tr>
<td>Bioavailability</td>
<td>Well characterized</td>
<td>Still being studied</td>
</tr>
</tbody>
</table>
<h2>Supplement Quality</h2>
<h3>ChromaDex Niagen</h3>
<ul>
<li>Most studied form</li>
<li>Licensed to multiple brands</li>
<li>Analytical certificates available</li>
</ul>
<h3>Quality Considerations</h3>
<ul>
<li>Purity testing important</li>
<li>NR can degrade to nicotinamide</li>
<li>Look for third-party testing</li>
</ul>
<h2>Relationships</h2>
<p>CONVERTED_TO::<a href="/garden/dev_admin/supplement/nmn/" class="internal-link">NMN</a> - Via NRK1/NRK2 kinases<br />
PRECURSOR_TO::<a class="internal-link is-unresolved" href="/404">NAD+</a> - Ultimate metabolic product<br />
ACTIVATES::<a href="/garden/dev_admin/protein/sirt1/" class="internal-link">SIRT1</a> - Via NAD+ elevation<br />
ACTIVATES::<a href="/garden/dev_admin/protein/sirt3/" class="internal-link">SIRT3</a> - Mitochondrial sirtuin<br />
SUPPORTS::<a href="/garden/dev_admin/cellularcomponent/mitochondria/" class="internal-link">Mitochondria</a> - Via NAD+ and sirtuins<br />
SUPPORTS::<a href="/garden/dev_admin/protein/pgc-1alpha/" class="internal-link">PGC-1alpha</a> - Via SIRT1 activation<br />
PARTICIPATES_IN_PATHWAY::<a href="/garden/dev_admin/pathway/nad-salvage-pathway/" class="internal-link">NAD+ Salvage Pathway</a><br />
SYNERGISTIC_WITH::<a href="/garden/dev_admin/supplement/resveratrol/" class="internal-link">Resveratrol</a> - Complementary SIRT1 effects<br />
SYNERGISTIC_WITH::<a class="internal-link is-unresolved" href="/404">Pterostilbene</a> - Enhanced NAD+ effects<br />
SYNERGISTIC_WITH::<a href="/garden/dev_admin/supplement/apigenin/" class="internal-link">Apigenin</a> - CD38 inhibition prevents NAD+ degradation<br />
ALTERNATIVE_TO::<a href="/garden/dev_admin/supplement/nmn/" class="internal-link">NMN</a> - Similar NAD+ precursor function<br />
AFFECTS_PROTEIN::<a class="internal-link is-unresolved" href="/404">PARP</a> - DNA repair enzyme<br />
RELATED_TO::<a class="internal-link is-unresolved" href="/404">Aging</a> - Longevity intervention<br />
RELATED_TO::<a class="internal-link is-unresolved" href="/404">Niacin</a> - Vitamin B3 family</p>
<h2>References</h2>
<ul>
<li>Trammell SA, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. PMID: 27721479</li>
<li>Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. PMID: 29599478</li>
<li>Yoshino J, et al. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018;27(3):513-528. PMID: 29249689</li>
</ul>

{% endraw %}